Chronic rhinosinusitis (CRS) is a surprisingly common but under-recognized disease that affects nearly one billion people worldwide, or about 12% of the population. Defined as a long-lasting ...

Polyp recurrence occurred in more than 1 in 3 patients with chronic rhinosinusitis with nasal polyps who underwent endoscopic sinus surgery, with several prognostic factors linked with recurrence.

Tezspire (tezepelumab-ekko) is a prescription medicine used to treat inflammatory conditions of the airways, such as severe asthma. The FDA has now approved it as an add-on treatment for adults and ...

GSK’s blockbuster hopes for depemokimab remain on track after the investigational long-acting asthma treatment has also been shown to reduce nasal polyps in a pair of phase 3 trials. The ANCHOR-1 and ...

Nasal polyps are noncancerous soft tissue growths that form in your nasal passages and sinuses. They’re often a result of inflammation from sinusitis, allergens, or other issues. Experts don’t know ...

Even after nasal polyps are removed, they can continue to cause complications. Here’s how to treat some common problems that can arise. Treating nasal polyps isn’t a one-and-done procedure. The ...

Clinical Associate Professor of Medicine, Department of Internal Medicine and Gastroenterology, MCP Hahnemann University, Philadelphia, Pennsylvania; Chief, Division of Internal Medicine, Department ...

Approval broadens indication for TEZSPIRE to a second disease characterized by epithelial-driven inflammation AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab -ekko) has been approved in the US for the ...

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...

If you have nasal polyps, you likely deal with a range of symptoms, including nasal congestion, loss of smell and taste, and facial pain and pressure. To treat those symptoms, your doctor may have ...